title: [Pancreatectomy for the pancreatic tumors].
abstract: 23 pancreatectomies were made on the reason of various tumors of the pancreas during the period of 2009-2012yy. 15 patients had duct adenocarcinoma, 4 - neuroendocrine neoplasia, 2 - intraductal papillary-mucinous tumor, 1 had metastase of renal-cell carcinoma and 1 was diagnosed with serous cystadenoma. Pancreatectomy was indicated in case of invasion of the whole pancreas or in case of multiple tumor focuses. By adenocarcinoma the pancreatecomy was abstained in case of large vessels (a. mesenterica suoerior, truncus coeliacus and hepatic arteries) invasion or remote metastases presense or impossibility of R0 resection. Metastases and vessel invasion were not considered as contraindication to pancreatectomy in patients with neuroendocrine lesions. 10 (43.5%) patients had postoperative complications; 2 patients died. The survival median was 7 months for the duct adenocarcinoma. Postoperative life duration for patients with other pancreatic tumors was 6-36 months.
authors.forename: V A
authors.initials: VA
authors.lastname: Kubyshkin
authors.forename: A G
authors.initials: AG
authors.lastname: Kriger
authors.forename: V A
authors.initials: VA
authors.lastname: Vishnevskiĭ
authors.forename: G G
authors.initials: GG
authors.lastname: Karmazanovskiĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Kochatkov
authors.forename: A N
authors.initials: AN
authors.lastname: Lebedeva
authors.forename: D S
authors.initials: DS
authors.lastname: Gorin
authors.forename: S V
authors.initials: SV
authors.lastname: Berelavichus
authors.forename: S O
authors.initials: SO
authors.lastname: Zagalov
authors.forename: E M
authors.initials: EM
authors.lastname: Filippova
mesh_terms: D000328:Adult; D000368:Aged; D003657:Decision Making; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome